ADRB2 and prostate carcinoma: Although several studies have highlighted the stimulatory effects of stress-related hormones on migration of prostate cancer cells [36, 37], the results of our study showed that ISO, a non-selective βAR agonist, presented no direct effect on migration and invasion of human prostate cancer PC-3 and DU145 cells.